StonvexLoading…
StonvexStonvexStonvexCore line items from ALHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $1.80B | $1.43B | $1.17B | $955.39M |
Operating Income | $-127.82M | $-128.64M | $-178.07M | $-5.26M |
Net Income | $-148.02M | $-149.55M | $-195.29M | $-22.93M |
EPS (Diluted) | $-0.79 | $-0.83 | $-1.14 | $-0.15 |
Total Assets | $591.88M | $633.86M | $630.89M | $338.50M |
Total Liabilities | $433.81M | $394.56M | $324.84M | $307.89M |
Cash & Equivalents | $202.90M | $409.55M | $466.60M | $207.31M |
Free Cash Flow OCF − CapEx | $-95.18M | $-69.20M | Not available | Not available |
Shares Outstanding | 188.95M | 187.28M | 187.19M | 164.06M |